FDA Shortages Log
Add-on Combination Therapy with Glimepiride, with or without Metformin A total of 441 patients with type 2 diabetes participated in a 24-week, randomized, double-blind, placebo-controlled study designed to assess the efficacy of Januvia in combination with glimepiride, with or without metformin
Dose reduction to the prior tolerated tier is the next option
HSA and FSA accounts are accepted, and patients can add the Precision Peptide Genetic Test for $298 after their first month to unlock deeper personalization insights for future treatment decisions
However, the difference in weight regain between GLP-1 and non-GLP-1 groups was also not statistically significant
Hair loss with GLP-1 drugs is rare but real, studies find The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest.